| Serial Number | 98298155 |
| Word Mark | ECHO |
| Filing Date | Monday, December 4, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, December 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 3, 2024 |
| Goods and Services | Custom manufacturing of cell culture and cell therapy apparatus and equipment for others; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies for others; custom manufacture of cellular therapies; information, advice and consultancy in relation to all the aforesaid |
| Goods and Services | Platform as a service (PaaS) featuring computer software platforms for developing cell therapies; providing temporary use of web-based software platforms for developing and characterizing cell lines; providing temporary use of non-downloadable computer software platforms for manufacturing cell-based therapies and analyzing data for purposes of process optimization and quality control; laboratory research in the field of biotechnology; scientific research, design and technological development services in the field of biotechnology, for the pharmaceutical and medical industry; scientific research, design and technological development services in the fields of scientific cell cultures, cell therapies, and gene-edited cell therapy equipment and apparatus; scientific research, design and development of manufacturing equipment, manufacturing systems and manufacturing processes in the fields of cell culture, cell therapy, and gene edited cell therapy, for others; scientific consultation services in the field of biotechnology, specifically in relation to cell culture, cell therapy, or gene edited cell therapy manufacturing; providing information with respect to scientific research in the field of stem cells, cell therapy and edited cell gene therapy; calibration of scientific apparatus, machines and equipment used for cell culture, cell therapy and edited cell gene therapy; industrial biotechnology statistical analysis to extract insights from cell line development experiments and data |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 4, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 4, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CELYNTRA THERAPEUTICS SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | MONT-SAINT-GUIBERT 1435 BE |
| Party Name | CELYNTRA THERAPEUTICS SA |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | MONT-SAINT-GUIBERT 1435 BE |
| Party Name | Ncardia B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | LEIDEN 2333BD NL |
| Event Date | Event Description |
| Monday, December 4, 2023 | NEW APPLICATION ENTERED |
| Wednesday, February 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 19, 2024 | ASSIGNED TO EXAMINER |
| Saturday, March 23, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, March 23, 2024 | NON-FINAL ACTION E-MAILED |
| Saturday, March 23, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 20, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 20, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 10, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, June 20, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 10, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, July 10, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, July 10, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, July 10, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, July 10, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sunday, August 4, 2024 | FINAL REFUSAL WRITTEN |
| Sunday, August 4, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Sunday, August 4, 2024 | FINAL REFUSAL E-MAILED |
| Wednesday, August 7, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, August 7, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, August 7, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, August 7, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, August 7, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, August 7, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 16, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, October 25, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 25, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 25, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, November 6, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 27, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 3, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |